BR112012015693A8 - métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda - Google Patents
métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sondaInfo
- Publication number
- BR112012015693A8 BR112012015693A8 BR112012015693A BR112012015693A BR112012015693A8 BR 112012015693 A8 BR112012015693 A8 BR 112012015693A8 BR 112012015693 A BR112012015693 A BR 112012015693A BR 112012015693 A BR112012015693 A BR 112012015693A BR 112012015693 A8 BR112012015693 A8 BR 112012015693A8
- Authority
- BR
- Brazil
- Prior art keywords
- kidney disease
- canine
- diagnosing
- methods
- probe
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Abstract
composições e métodos para diagnosticar e tratar doença renal em um canico a presente invenção fornece métodos para: diagnosticar, elaborar e monitorar um plano de tratamento para, e monitorar o estado de uma doença renal caracterizada por uma perda anormal da função renal, falha renal, taxa de filtração glomerular reduzido ou glomerulonefrite, em um canino, em que a doença renal é detectável usando pelo menos um biomarcador relevante isolado e medido de uma amostra de teste biológico tirada de tal canino. a invenção adicionalmente relaciona a composições, reagentes e kits para realizar os métodos específicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28977309P | 2009-12-23 | 2009-12-23 | |
PCT/US2010/062031 WO2011079280A2 (en) | 2009-12-23 | 2010-12-23 | Compositions and methods for diagnosing and treating kidney disorders in a canine |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112012015693A2 BR112012015693A2 (pt) | 2018-05-29 |
BR112012015693A8 true BR112012015693A8 (pt) | 2018-06-26 |
Family
ID=43927763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012015693A BR112012015693A8 (pt) | 2009-12-23 | 2010-12-23 | métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda |
Country Status (10)
Country | Link |
---|---|
US (1) | US9476868B2 (pt) |
EP (1) | EP2517020B1 (pt) |
JP (2) | JP6199558B2 (pt) |
CN (1) | CN102713632B (pt) |
AU (1) | AU2010336392B2 (pt) |
BR (1) | BR112012015693A8 (pt) |
CA (1) | CA2785406A1 (pt) |
RU (1) | RU2546016C2 (pt) |
WO (1) | WO2011079280A2 (pt) |
ZA (2) | ZA201204531B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3067107C (en) | 2010-06-03 | 2022-07-12 | Idexx Laboratories, Inc. | Markers for renal disease |
CA2827200A1 (en) * | 2011-02-24 | 2012-08-30 | Hill's Pet Nutrition, Inc. | Compositions and methods for diagnosing and treating kidney disorders in a feline |
WO2013068776A1 (en) * | 2011-11-09 | 2013-05-16 | Università Degli Studi Di Bari | Combination of active ingredients for the treatment of acute kidney injury |
KR101609113B1 (ko) * | 2013-11-20 | 2016-04-05 | 영동제약 주식회사 | 신부전증 진단용 키트 및 그 방법 |
ES2821966T3 (es) * | 2014-04-02 | 2021-04-28 | Nitto Denko Corp | Molécula de direccionamiento derivada de RBP y utilización de la misma |
AR107786A1 (es) * | 2016-03-02 | 2018-06-06 | Idexx Lab Inc | Métodos y composiciones para la detección y el diagnóstico de enfermedad renal y enfermedad periodontal |
WO2018094221A1 (en) * | 2016-11-18 | 2018-05-24 | Mayo Foundation For Medical Education And Research | Assessing and treating fibrillary glomerulonephritis |
JP2018096710A (ja) * | 2016-12-08 | 2018-06-21 | 国立大学法人金沢大学 | 血中タンパク質を測定することにより、ネフローゼ症候群の疾患活動性を判定する方法 |
CN109293763B (zh) * | 2018-10-26 | 2021-10-26 | 中国农业科学院特产研究所 | 水貂激活素b蛋白及其制备与应用 |
KR102167792B1 (ko) * | 2019-10-01 | 2020-10-19 | 대한민국 | 개의 고칼슘혈증 조기 예측 또는 진단용 조성물 |
CN111733140B (zh) * | 2020-04-04 | 2022-07-01 | 华中农业大学 | 一种抗犬基质金属蛋白酶的杂交瘤细胞株及其制备方法和一种单克隆抗体及其应用 |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60153762A (ja) | 1984-01-24 | 1985-08-13 | Nippon Nousan Kogyo Kk | 家畜、家禽用飼料 |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5333675C1 (en) | 1986-02-25 | 2001-05-01 | Perkin Elmer Corp | Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5856092A (en) | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US6309822B1 (en) | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
EP0624059A4 (en) | 1991-11-22 | 1994-12-21 | Affymax Technologies N.V. | Combinatorial strategies for polymer synthesis. |
US5541061A (en) | 1992-04-29 | 1996-07-30 | Affymax Technologies N.V. | Methods for screening factorial chemical libraries |
JP3954092B2 (ja) | 1993-06-25 | 2007-08-08 | アフィメトリックス インコーポレイテッド | 核酸配列のハイブリダイゼーションと配列決定 |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
US6156501A (en) | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
JPH08191668A (ja) | 1994-11-18 | 1996-07-30 | Lion Corp | ペットフード |
US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
US6811995B1 (en) | 1996-04-26 | 2004-11-02 | Children's Medical Center Corporation | Non-invasive enzyme screen for cancer |
KR20000029575A (ko) | 1996-08-01 | 2000-05-25 | 다께다 가즈히꼬 | 장기이식후의만성거부반응의검사방법및뇨중성분의측정방법 |
JP3693352B2 (ja) | 1997-06-13 | 2005-09-07 | アフィメトリックス インコーポレイテッド | プローブアレイを使用して、遺伝子多型性を検出し、対立遺伝子発現をモニターする方法 |
US6333179B1 (en) | 1997-06-20 | 2001-12-25 | Affymetrix, Inc. | Methods and compositions for multiplex amplification of nucleic acids |
WO1999023254A1 (en) | 1997-10-31 | 1999-05-14 | Affymetrix, Inc. | Expression profiles in adult and fetal organs |
US6013449A (en) | 1997-11-26 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Probe-based analysis of heterozygous mutations using two-color labelling |
US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
AU769669B2 (en) | 1998-09-02 | 2004-01-29 | Heska Corporation | Method and composition to protect an obligate carnivore from a disease of abnormal carbohydrate metabolism |
US7763580B2 (en) | 1999-01-05 | 2010-07-27 | University Of Utah Research Foundation | Methods for treating conditions associated with the accumulation of excess extracellular matrix |
US6177248B1 (en) | 1999-02-24 | 2001-01-23 | Affymetrix, Inc. | Downstream genes of tumor suppressor WT1 |
US6300070B1 (en) | 1999-06-04 | 2001-10-09 | Mosaic Technologies, Inc. | Solid phase methods for amplifying multiple nucleic acids |
US7482135B2 (en) | 2000-05-17 | 2009-01-27 | Nederlandse Organisatie Voor Toegepast | Proteolytic enzymes in urine as diagnostic parameters in diseases involving matrix remodelling |
AU2001281322A1 (en) | 2000-07-13 | 2002-01-30 | Biogen, Inc. | Methods of identifying renal protective factors |
US20030073100A1 (en) | 2001-03-30 | 2003-04-17 | Peyman John A. | Method of identifying renalgenerative agents using differential gene expression |
AU2002305193A1 (en) * | 2001-04-18 | 2002-11-05 | Wyeth | Methods and reagents for regulating bone and cartilage formation |
NZ530457A (en) | 2001-06-01 | 2007-12-21 | Biogen Idec Inc | Molecules and methods for inhibiting shedding of KIM-1 |
AU2002362055A1 (en) | 2001-12-03 | 2003-06-17 | Oncomedx, Inc. | Detection of matrix metalloproteinase rna in plasma and serum |
WO2003097615A1 (en) | 2002-05-17 | 2003-11-27 | Scios, Inc. | TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-β INHIBITORS |
GB0215509D0 (en) | 2002-07-04 | 2002-08-14 | Novartis Ag | Marker genes |
WO2004005934A2 (en) | 2002-07-04 | 2004-01-15 | Oxford Glycosciences (Uk) Ltd | Toxicity markers |
US7560244B2 (en) | 2003-06-04 | 2009-07-14 | Joslin Diabetes Center, Inc. | Method of evaluating a subject for risk or predisposition of reduced renal function over time |
WO2006089268A2 (en) * | 2005-02-18 | 2006-08-24 | The University Of North Carolina At Chapel Hill | Gene and cognate protein profiles and methods to determine connective tissue markers in normal and pathologic conditions |
US20060253262A1 (en) * | 2005-04-27 | 2006-11-09 | Emiliem | Novel Methods and Devices for Evaluating Poisons |
US8158107B2 (en) | 2005-09-30 | 2012-04-17 | National Jewish Health | Genes and proteins associated with angiogenesis and uses thereof |
EP1808694A1 (en) * | 2006-01-17 | 2007-07-18 | Universitätsklinikum Freiburg | Method for diagnosing polycystic kidney disease |
TW200728718A (en) | 2006-01-20 | 2007-08-01 | Nat Defense Medical Ct | Biomarkers for diagnosis of crescentic glomerulonephritis |
-
2010
- 2010-12-23 AU AU2010336392A patent/AU2010336392B2/en active Active
- 2010-12-23 JP JP2012546238A patent/JP6199558B2/ja active Active
- 2010-12-23 CA CA2785406A patent/CA2785406A1/en not_active Abandoned
- 2010-12-23 CN CN201080059274.8A patent/CN102713632B/zh not_active Expired - Fee Related
- 2010-12-23 WO PCT/US2010/062031 patent/WO2011079280A2/en active Application Filing
- 2010-12-23 EP EP10807768.6A patent/EP2517020B1/en active Active
- 2010-12-23 US US13/519,048 patent/US9476868B2/en active Active
- 2010-12-23 BR BR112012015693A patent/BR112012015693A8/pt not_active IP Right Cessation
- 2010-12-23 RU RU2012131367/15A patent/RU2546016C2/ru not_active IP Right Cessation
-
2012
- 2012-06-19 ZA ZA2012/04531A patent/ZA201204531B/en unknown
-
2014
- 2014-10-28 ZA ZA2014/07857A patent/ZA201407857B/en unknown
-
2016
- 2016-12-13 JP JP2016241219A patent/JP6174777B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
BR112012015693A2 (pt) | 2018-05-29 |
CN102713632B (zh) | 2015-10-07 |
RU2012131367A (ru) | 2014-01-27 |
ZA201407857B (en) | 2015-04-29 |
CA2785406A1 (en) | 2011-06-30 |
JP6174777B2 (ja) | 2017-08-02 |
US20120283129A1 (en) | 2012-11-08 |
EP2517020B1 (en) | 2015-10-21 |
CN102713632A (zh) | 2012-10-03 |
WO2011079280A3 (en) | 2011-11-17 |
EP2517020A2 (en) | 2012-10-31 |
RU2546016C2 (ru) | 2015-04-10 |
ZA201204531B (en) | 2015-08-26 |
AU2010336392B2 (en) | 2014-01-23 |
AU2010336392A1 (en) | 2012-06-21 |
US9476868B2 (en) | 2016-10-25 |
JP2013515489A (ja) | 2013-05-09 |
JP6199558B2 (ja) | 2017-09-20 |
WO2011079280A2 (en) | 2011-06-30 |
JP2017079763A (ja) | 2017-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012015693A8 (pt) | métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda | |
BR112014007214A2 (pt) | predição de evento de risco cardiovascular e utilização do mesmo | |
BR112013003391A2 (pt) | biomarcadores de câncer pancreático e usos dos mesmos | |
BR112012019542A2 (pt) | "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit" | |
BR112012021202A2 (pt) | aparelho e metodos para preparacao, reacao e deteccao integradas de amostras | |
HRP20130127T1 (hr) | Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega | |
NZ605698A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
BR112014011818A2 (pt) | método para realizar ensaios de quantificação | |
EP4235181A3 (en) | Biomarker detection process and assay of neurological condition | |
NZ630277A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
BRPI0718322A2 (pt) | Métodos para diagnosticar uma suscetibilidade para câncer em um indivíduo humano, para identificar um marcador para o uso na avaliação da suscetibilidade para câncer, para genotipar uma amostra de ácido nucléico, para avaliar um inidivíduo quanto a probabilidade de resposta a um agente terapêutico, para predizer o prognóstico e para monitorar o progresso de um tratamento de um indivíduo, kit para avaliar a suscetibilidade para câncer em um indivíduo, uso de uma sonda de oligonucleotídeo, meio legível por computador, e, aparelho para determinar um indicador genético para câncer em um indivíduo. | |
IN2014CN01787A (pt) | ||
ATE554389T1 (de) | Apex als marker für lungenkrebs | |
NZ705411A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
DK1974210T3 (da) | Fremgangsmåde til diagnosticering af polycystisk nyresygdom | |
BR112013000869A2 (pt) | método para diagnóstico de câncer de próstata (pca) com uma sensibilidade desejada em um sujeito; método para monitorar a progressão do câncer de próstata (pca) em um sujeito; método para avaliar se um sujeito tem que ser submetido a uma biópsia de próstata; kit compreendendo um primeiro componente e, opcionalmente, um segundo componente e uso de um kit | |
WO2010099137A3 (en) | In situ methods for monitoring the emt status of tumor cells in vivo | |
CO6311041A2 (es) | Un metodo para determinar y monitorear un cancer ginecologico que comprende la determinacion de niveles de biomarcadores en una muestra biologica | |
WO2010136163A8 (en) | Secernin-1 as a marker for cancer | |
WO2009149319A3 (en) | Gene expression profiles associated with asthma exacerbation attacks | |
BR112014031957A2 (pt) | bag3 como soro bioquímico e marcador de tecido | |
BR112022007386A2 (pt) | Métodos para tratar um câncer hematológico e o uso de biomarcadores companheiros para 2-(2,6-dioxopiperidin-3-il)-4-((2-fluoro-4-((3-morfolinoazetidin-1-il)metil)benzil)amino)isoindolina-1,3-diona | |
ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
BR112012024175A2 (pt) | hbf e a1m como marcadores de estágio precoce para preeclampsia | |
WO2011018710A3 (en) | Biological components within the cerebrospinal fluid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30/10/2018. |